Sign in
4

Changes in Ownership

GT Biopharma, Inc. Filed Acc 0000109657-07-000002

Options or other derivatives

  • Director acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
SPOLAR MATTHEW R Director 2007-01-11 Grant or award · Stock Option +30,000 30,000 D
Loading xslF345X02/primary_doc.xml…